THE KOREA REGENERATIVE MEDICINE GUIDE
Evidence
Preclinical research: before a treatment reaches people
Laboratory and animal findings are important steps, but cannot establish clinical benefit on their own.
“Use this guide to frame clear, indication-specific questions for your specialist consultation.”
PATIENT EVIDENCE & CONSULTATION GUIDE
Category: Evidence · Editorial Review: Updated 20 October 2026 · 3 minute read
What preclinical means
Preclinical research takes place before or alongside human testing and may use cultured cells, tissue models, or animals. It can investigate a proposed mechanism, identify possible hazards, and help design a clinical study. These findings are essential to development, but a result in a model is not the same as a demonstrated benefit in people with the condition.
Why translation is difficult
Human disease can differ from an experimental model in duration, severity, age, coexisting illness, and prior treatment. The way cells are delivered in a laboratory may also differ from a practical clinical procedure. A model may measure a biological marker rather than daily function or quality of life. These differences explain why promising findings need careful clinical testing.
Read the headline and the methods
When a clinic cites a breakthrough, check whether participants were people, animals, or cells in a dish. Look for the exact product and the measured outcome. A headline about regeneration can refer to a laboratory observation rather than a recovered human ability. Asking these questions does not diminish research; it places the result at the correct stage of development.
What evidence should follow
A credible development pathway explains why the preclinical findings justify a particular human study and how safety will be monitored. Patients should ask what human data already exist and what remains unknown. If only laboratory evidence is available, the discussion should identify the intervention as investigational rather than presenting the proposed biological effect as a predictable patient outcome.
Continue exploring
- Blinding and placebo effects
- Clinical endpoints: what counts as improvement
- Surrogate markers and biological age claims
- Prepare your consultation checklist
Sources & further reading
- NIH — Stem Cell Basics
- ISSCR — Guide to Stem Cell Treatments
- National Cancer Institute — How Clinical Trials Work
Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.
CONTINUE YOUR PREPARATION
Prepare for your clinical conversation.
Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.
CELLARIUM
Knowledge before possibility.
Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.
© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.